Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 23, 2015, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $987.00 to $64,149,572.70.

Highlighted Stocks Traded by Insiders:

Healthcare Realty (HR) - FREE Research Report

Fernandez Charles Raymond, who is Director at Healthcare Realty, sold 3,000 shares at $27.94 on March 23, 2015. Following this transaction, the Director owned 17,214 shares meaning that the stake was reduced by 14.84% with the 3,000-share transaction.

The shares most recently traded at $28.06, up $0.12, or 0.44% since the insider transaction. Historical insider transactions for Healthcare Realty go as follows:

  • 4-Week # shares bought: 379
  • 4-Week # shares sold: 6,000
  • 12-Week # shares bought: 1,552
  • 12-Week # shares sold: 6,000
  • 24-Week # shares bought: 1,552
  • 24-Week # shares sold: 6,000

The average volume for Healthcare Realty has been 692,000 shares per day over the past 30 days. Healthcare Realty has a market cap of $2.8 billion and is part of the financial sector and real estate industry. Shares are up 2.71% year-to-date as of the close of trading on Monday.

Healthcare Realty Trust Incorporated is an independent real estate investment trust. The firm invests in real estate markets of the United States. The stock currently has a dividend yield of 4.27%. The company has a P/E ratio of 80.3. Currently, there are no analysts who rate Healthcare Realty a buy, 2 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HR - FREE

TheStreet Quant Ratings

rates Healthcare Realty as a

buy

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Healthcare Realty Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Burlington Stores (BURL) - FREE Research Report

Katz Marc, who is EVP & Chief Financial Officer at Burlington Stores, sold 12,000 shares at $59.65 on March 23, 2015. Following this transaction, the EVP & Chief Financial Officer owned 121,159 shares meaning that the stake was reduced by 9.01% with the 12,000-share transaction.

The shares most recently traded at $60.68, up $1.03, or 1.7% since the insider transaction. Historical insider transactions for Burlington Stores go as follows:

  • 4-Week # shares sold: 79,000
  • 12-Week # shares sold: 234,304
  • 24-Week # shares sold: 400,819

The average volume for Burlington Stores has been 1.0 million shares per day over the past 30 days. Burlington Stores has a market cap of $4.5 billion and is part of the services sector and retail industry. Shares are up 27.59% year-to-date as of the close of trading on Monday.

Burlington Stores, Inc. operates as a retailer of branded apparel products in the United States. The company provides fashion-focused merchandise, such as women's ready-to-wear apparel, menswear, youth apparel, baby products, footwear, accessories, home goods, and coats. Currently, there are 9 analysts who rate Burlington Stores a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BURL - FREE

TheStreet Quant Ratings

rates Burlington Stores as a

sell

. The area that we feel has been the company's primary weakness has been its weak operating cash flow. Get the full

Burlington Stores Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

United States Cellular (USM) - FREE Research Report

Crowley J Samuel, who is Director at United States Cellular, sold 2,174 shares at $37.99 on March 23, 2015. Following this transaction, the Director owned 4,144 shares meaning that the stake was reduced by 34.41% with the 2,174-share transaction.

The shares most recently traded at $37.62, down $0.37, or 0.97% since the insider transaction. Historical insider transactions for United States Cellular go as follows:

  • 4-Week # shares sold: 406
  • 12-Week # shares sold: 406
  • 24-Week # shares sold: 406

The average volume for United States Cellular has been 107,100 shares per day over the past 30 days. United States Cellular has a market cap of $1.9 billion and is part of the technology sector and telecommunications industry. Shares are down 4.82% year-to-date as of the close of trading on Monday.

United States Cellular Corporation provides wireless telecommunications services in the United States. Currently, there are 3 analysts who rate United States Cellular a buy, 2 analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on USM - FREE

TheStreet Quant Ratings

rates United States Cellular as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full

United States Cellular Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null